Journals / Forbes tıp dergisi (Online) / 2021 / Cilt: 2 - Sayı: 3

Mitral Valve Obstruction Caused by Heart-shaped Large Left Atrial Myxoma

Mitral Kapak Obstrüksiyonuna Neden Olan Kalp Şekilli Dev Sol Atrial Miksoma

Pages
182–184
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This paper describes a patient with a large left atrial myxoma, causing mitral valve obstruction

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Myxoma is one of the most common benign primary cardiac tumors, usually detected at ages between 30 and 60 years.
📊
Key Findings & Data:It accounts for 50% of the primary cardiac tumors.
💡
Conclusion & Impact:This paper describes a patient with a large left atrial myxoma, causing mitral valve obstruction
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Myxoma is one of the most common benign primary cardiac tumors, usually detected at ages between 30 and 60 years. It accounts for 50% of the primary cardiac tumors. The most common location of a myxoma is the left atrium. Myxomas are more prevalent in females. The clinical outcomes can differ depending on the tumor’s size, location, and architecture. The clinical picture can mimic mitral stenosis, which causes mitral valve obstruction. Syncope is a rare but life-threatening symptom and requires early surgical treatment. This paper describes a patient with a large left atrial myxoma, causing mitral valve obstruction

Özet

Miksoma, çoğunlukla 30 ile 60 yaşlar arasında saptanan ve en sık görülen benign primer kardiyak tümördür. Primer kardiyak tümörlerin yaklaşık %50'sini oluşturur. En sık sol atriyum yerleşimlidirler ve kadınlarda daha sık görülür. Miksomalar; büyüklüğüne, yüzey yapısına ve bulundukları kalp boşluklarına göre farklı klinik tabloya neden olabilirler. Mitral kapak obstrüksiyonuna neden olarak mitral darlığı semptomlarını ortaya çıkarabilirler. Senkop nadir görülen ancak hayatı tehdit edebilen bir semptom olup erken cerrahi tedavi gerektirir. Bu yazıda mitral kapak obstrüksiyonuna neden olan dev sol atrial miksomalı nadir bir olgu sunulmuştur

🔖

Cite This Article

EMREN, V., EMREN, Z. Y., ŞENÖZ, O., YURDAM, F., TOMAKİN, F. N. (2022). Mitral Valve Obstruction Caused by Heart-shaped Large Left Atrial Myxoma. Forbes tıp dergisi (Online), Cilt: 2 - Sayı: 3, 182–184. https://ajindex.com/articles/517907

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Butany J, Nair V, Naseemuddin A, Nair GM, Catton C, Yau T. Cardiac tumours: diagnosis and management. Lancet Oncol. 2005;6:219-28
  2. Tasoglu I, Tutun U, Lafci G, et al. Primary cardiac myxomas: clinical experience and surgical results in 67 patients. J Card Surg. 2009;24:256-9
  3. Pinede L, Duhaut P, Loire R. Clinical presentation of left atrial cardiac myxoma. A series of 112 consecutive cases. Medicine (Baltimore). 2001;80:159-72
  4. Parry AJ, Pillaj R. Miscellaneous cardiac disease. In: Morris PJ, Malt RA (ed). Oxford Textbook of Surgery, Vol 2, 1994, Oxford: Oxford University Press;1848-54
  5. Rashidi N, Montazeri M, Montazeri M. Large Left Atrial Myxoma Causing Mitral Valve Obstruction: A Rare Cause of Syncope. J Cardiovasc Echogr. 2014;24:125-7
  6. El Sabbagh A, Al-Hijji MA, Thaden JJ, et al. Cardiac Myxoma: The Great Mimicker. JACC Cardiovasc Imaging. 2017;10:203-6
  7. Spartalis M, Tzatzaki E, Spartalis E, et al. Atrial Myxoma Mimicking Mitral Stenosis. Cardiol Res. 2017;8:128-30
  8. Pitt A, Pitt B, Schaefer J, Criley JM. Myxoma of the left atrium. Hemodynamic and phonocardiographic consequences of sudden tumor movement. Circulation. 1967;36:408-16
  9. Baikoussis NG, Siminelakis SN, Kotsanti A, Achenbach K, Argyropoulou M, Goudevenos J. Multiple cerebral mycotic aneurysms due to left atrial myxoma: are there any pitfalls for the cardiac surgeon? Hellenic J Cardiol. 2011;52:466-8
  10. Ren DY, Fuller ND, Gilbert SAB, Zhang Y. Cardiac Tumors: Clinical Perspective and Therapeutic Considerations. Curr Drug Targets. 2017;18:1805